Myelofibrotic transformation is a known complication of essential thrombocythaemia (ET),
but information on its incidence, presenting features and evolution is scarce. In a series of …

The dependence of survival time on a set of prognostic factors was explored by means of
Cox's regression model in 137 cases of myelofibrosis with myeloid metaplasia (MMM). The …

The prognostic value of 12 clinical and haematological parameters, recorded at diagnosis,
in myelofibrosis with myeloid metaplasia (MMM) was retrospectively analysed in a …

BACKGROUND AND OBJECTIVES: Diagnosis of essential thrombocythemia (ET) remains a
challenging problem and has been predominantly established by exclusion of other …

A quantitative assessment of erythropoiesis was performed by means of a mathematical
model of iron kinetics in 26 patients with myelofibrosis with myeloid metaplasia (MMM). A …

The prognostic significance of cytogenetic abnormalities was determined in 106 patients
with well‐characterized idiopathic myelofibrosis who were successfully karyotyped at …

Between January 1985 and December 1992, 104 consecutive patients with symptomatic
myelofibrosis with myeloid metaplasia (MMM)[splenic enlargement> 5 cm and/or …

Idiopathic myelofibrosis, or agnogenic myeloid metaplasia. is a chronic neoplastic disorder
characterized by bone marrow fibrosis, extramedullary haemopoiesis, splenomegaly and a …

Myelofibrosis with myeloid metaplasia (MMM) is uniquely characterized by macroscopic
bone marrow stromal changes that are believed to be both reactive and cytokine mediated …

Among 2333 consecutive patients with myelofibrosis with myeloid metaplasia (MMM) seen
at our institution, 91 fulfilled the World Health Organization (WHO) criteria for leukemic …